202 related articles for article (PubMed ID: 26567890)
1. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.
Nustede R; Klimiankou M; Klimenkova O; Kuznetsova I; Zeidler C; Welte K; Skokowa J
Br J Haematol; 2016 Jan; 172(2):219-27. PubMed ID: 26567890
[TBL] [Abstract][Full Text] [Related]
2. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
[TBL] [Abstract][Full Text] [Related]
3. New insights into the pathomechanism of cyclic neutropenia.
Mir P; Klimiankou M; Findik B; Hähnel K; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
Ann N Y Acad Sci; 2020 Apr; 1466(1):83-92. PubMed ID: 32083314
[TBL] [Abstract][Full Text] [Related]
4. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
5. Four novel ELANE mutations in patients with congenital neutropenia.
Kurnikova M; Maschan M; Dinova E; Shagina I; Finogenova N; Mamedova E; Polovtseva T; Shagin D; Shcherbina A
Pediatr Blood Cancer; 2011 Aug; 57(2):332-5. PubMed ID: 21425445
[TBL] [Abstract][Full Text] [Related]
6. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane.
Nanua S; Murakami M; Xia J; Grenda DS; Woloszynek J; Strand M; Link DC
Blood; 2011 Mar; 117(13):3539-47. PubMed ID: 21285438
[TBL] [Abstract][Full Text] [Related]
7. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
[TBL] [Abstract][Full Text] [Related]
8. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia.
Makaryan V; Zeidler C; Bolyard AA; Skokowa J; Rodger E; Kelley ML; Boxer LA; Bonilla MA; Newburger PE; Shimamura A; Zhu B; Rosenberg PS; Link DC; Welte K; Dale DC
Curr Opin Hematol; 2015 Jan; 22(1):3-11. PubMed ID: 25427142
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells.
Nayak RC; Trump LR; Aronow BJ; Myers K; Mehta P; Kalfa T; Wellendorf AM; Valencia CA; Paddison PJ; Horwitz MS; Grimes HL; Lutzko C; Cancelas JA
J Clin Invest; 2015 Aug; 125(8):3103-16. PubMed ID: 26193632
[TBL] [Abstract][Full Text] [Related]
10. A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.
Qiu Y; Zhang Y; Hu N; Dong F
J Biol Chem; 2017 Feb; 292(8):3496-3505. PubMed ID: 28073911
[TBL] [Abstract][Full Text] [Related]
11. Reduced ELANE and SLPI expression compromises dental pulp cell activity.
Sriwattanapong K; Sa-Ard-Iam N; Boonprakong L; Subbalekha K; Trachoo V; Suratannon N; Porntaveetus T; Shotelersuk V
Cell Prolif; 2021 Nov; 54(11):e13132. PubMed ID: 34580954
[TBL] [Abstract][Full Text] [Related]
12. Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene.
Komvilaisak P; Yudhasompop N; Kanchanakamhaeng K; Hongeng S; Pakakasama S; Anurathapan U; Pongphitcha P; Songdej D; Sasanakul W; Sirachainan N
BMC Pediatr; 2023 Nov; 23(1):592. PubMed ID: 37993852
[TBL] [Abstract][Full Text] [Related]
13. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.
Horwitz MS; Corey SJ; Grimes HL; Tidwell T
Hematol Oncol Clin North Am; 2013 Feb; 27(1):19-41, vii. PubMed ID: 23351986
[TBL] [Abstract][Full Text] [Related]
14. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes.
Newburger PE; Pindyck TN; Zhu Z; Bolyard AA; Aprikyan AA; Dale DC; Smith GD; Boxer LA
Pediatr Blood Cancer; 2010 Aug; 55(2):314-7. PubMed ID: 20582973
[TBL] [Abstract][Full Text] [Related]
15. Elastase inhibitors as potential therapies for
Makaryan V; Kelley ML; Fletcher B; Bolyard AA; Aprikyan AA; Dale DC
J Leukoc Biol; 2017 Oct; 102(4):1143-1151. PubMed ID: 28754797
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of Neutropenia-Associated Neutrophil Elastase Mutations in a Murine Differentiation Model In Vitro and In Vivo.
Wiesmeier M; Gautam S; Kirschnek S; Häcker G
PLoS One; 2016; 11(12):e0168055. PubMed ID: 27942017
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil Elastase Defects in Congenital Neutropenia.
Rydzynska Z; Pawlik B; Krzyzanowski D; Mlynarski W; Madzio J
Front Immunol; 2021; 12():653932. PubMed ID: 33968054
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis.
Grenda DS; Murakami M; Ghatak J; Xia J; Boxer LA; Dale D; Dinauer MC; Link DC
Blood; 2007 Dec; 110(13):4179-87. PubMed ID: 17761833
[TBL] [Abstract][Full Text] [Related]
19. Spectrum of
Arun AK; Senthamizhselvi A; Hemamalini S; Edison ES; Korula A; Fouzia NA; George B; Mathews V; Balasubramanian P
J Clin Pathol; 2018 Dec; 71(12):1046-1050. PubMed ID: 30171085
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the defective granulopoiesis in childhood cyclic neutropenia and in severe congenital neutropenia.
Sera Y; Kawaguchi H; Nakamura K; Sato T; Habara M; Okada S; Ishikawa N; Kojima S; Katoh O; Kobayashi M
Haematologica; 2005 Aug; 90(8):1032-41. PubMed ID: 16079102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
